The activated immune system in congestive heart failure – from dropsy to the cytokine paradigm
Open Access
- 1 February 1998
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 243 (2) , 87-92
- https://doi.org/10.1046/j.1365-2796.1998.00265.x
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Role of Cytokines in the Mechanism of Action of Amlodipine: The PRAISE Heart Failure TrialJournal of the American College of Cardiology, 1997
- Elevated soluble CD14 receptors and altered cytokines in chronic heart failureThe American Journal of Cardiology, 1997
- Wasting as independent risk factor for mortality in chronic heart failurePublished by Elsevier ,1997
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Differential Modulation of Cytokine Production by Drugs: Implications for Therapy in Heart FailureJournal of Molecular and Cellular Cardiology, 1996
- Activation of the neuroendocrine response in heart failure: Adaptive or maladaptive process?Cardiovascular Drugs and Therapy, 1996
- Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrationsCritical Care Medicine, 1996
- Is Tumor Necrosis Factor an Important Neurohormonal Mechanism in Chronic Heart Failure?Circulation, 1995
- Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart FailureCirculation, 1995
- How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the diseaseThe American Journal of Cardiology, 1993